Michael S. Kinch
Profile
Michael S.
Kinch is Head of Product and Business Development for Functional Genetics, Inc. He is Director of Scientific Advisory Boards for Alfacell Corp.
& Vasgene Therapeutics, Inc. and Chairman of the Synergistic Idea Award Program for the Department of Defense CDMRP.
Prior to joining Functional Genetics he was Associate Professor of Cellular Pharmacology at Purdue University in 1996.
Previously he was Senior Director of Biology of MedImmune, Inc. Dr. Kinch received a PhD in Microbiology and Immunology from the Duke University Medical Center.
He conducted post-doctoral fellow at the University of North Carolina.
Former positions of Michael S. Kinch
| Companies | Position | End |
|---|---|---|
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - |
| Purdue University | Corporate Officer/Principal | - |
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Director/Board Member | - |
VasGene Therapeutics, Inc.
 VasGene Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services VasGene Therapeutics, Inc. developed therapeutics based on vascular biology. Its products included target signal transduction pathways common to cancer cells and endothelial cells, resulting in anti-cancer agents with multiple modes of action and inhibition of tumor cell growth, anti-angiogenesis and prevention of tumor cell metastasis. The company was founded by Raymond A. Mirra Jr. and Parkash Gill in 1999 and was headquartered in Oak Park, CA. | Director/Board Member | - |
Functional Genetics, Inc.
 Functional Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Functional Genetics, Inc. operated as a biotechnology company. Its products facilitate simultaneous targeting of multiple co-morbid pathogens with a single drug. The company provided antiviral drugs that demonstrate beneficial activity against various viruses, included HIV, RSV, influenza, hepatitis viruses, herpes and bio-threat pathogens. Functional Genetics was founded in 1987 and was headquartered in Palo Alto, CA. | Chief Tech/Sci/R&D Officer | - |
Training of Michael S. Kinch
| Duke University | Doctorate Degree |
Experiences
Positions held
Linked companies
| Private companies | 4 |
|---|---|
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
VasGene Therapeutics, Inc.
VasGene Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services VasGene Therapeutics, Inc. developed therapeutics based on vascular biology. Its products included target signal transduction pathways common to cancer cells and endothelial cells, resulting in anti-cancer agents with multiple modes of action and inhibition of tumor cell growth, anti-angiogenesis and prevention of tumor cell metastasis. The company was founded by Raymond A. Mirra Jr. and Parkash Gill in 1999 and was headquartered in Oak Park, CA. | Commercial Services |
Functional Genetics, Inc.
Functional Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Functional Genetics, Inc. operated as a biotechnology company. Its products facilitate simultaneous targeting of multiple co-morbid pathogens with a single drug. The company provided antiviral drugs that demonstrate beneficial activity against various viruses, included HIV, RSV, influenza, hepatitis viruses, herpes and bio-threat pathogens. Functional Genetics was founded in 1987 and was headquartered in Palo Alto, CA. | Commercial Services |
- Stock Market
- Insiders
- Michael S. Kinch
